Decidual stromal cells for the treatment of severe COVID-19 ARDS
- PMID: 37968285
- DOI: 10.1007/s00134-023-07262-x
Decidual stromal cells for the treatment of severe COVID-19 ARDS
References
-
- Lamers MM, Haagmans BL (2022) SARS-CoV-2 pathogenesis. Nat Rev Microbiol 20:270–284. https://doi.org/10.1038/s41579-022-00713-0 - DOI - PubMed
-
- Wang W, Lei W, Jiang L, Gao S, Hu S, Zhao ZG, Niu CY, Zhao ZA (2021) Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment. J Transl Med 19:198. https://doi.org/10.1186/s12967-021-02862-x - DOI - PubMed - PMC
-
- Zanirati G, Provenzi L, Libermann LL, Bizotto SC, Ghilardi IM, Marinowic DR, Shetty AK, Da Costa JC (2021) Stem cell-based therapy for COVID-19 and ARDS: a systematic review. NPJ Regen Med 6:73. https://doi.org/10.1038/s41536-021-00181-9 - DOI - PubMed - PMC
-
- Erkers T, Nava S, Yosef J, Ringden O, Kaipe H (2013) Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner. Stem Cells Dev 22:2596–2605. https://doi.org/10.1089/scd.2013.0079 - DOI - PubMed
-
- Ringden O, Baygan A, Remberger M, Gustafsson B, Winiarski J, Khoein B, Moll G, Klingspor L, Westgren M, Sadeghi B (2018) Placenta-derived decidua stromal cells for treatment of severe acute graft-versus-host disease. Stem Cells Transl Med 7:325–331. https://doi.org/10.1002/sctm.17-0167 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical